Glaucoma Medication Adherence: What Practices Can Actually Do

Glaucoma treatment fails quietly. The drops work; the disease is controllable; and yet roughly half of patients are substantially off their regimen within a year — usually without telling anyone. The physician sees a pressure creeping up and escalates therapy, when the real problem is that the first therapy lives unopened in a bathroom drawer. Adherence isn't a patient-character issue a practice can lecture away; it's a system design problem practices can meaningfully improve.

Find the nonadherence before the pressure does

• Ask better. Replace 'are you taking your drops?' (which invites yes) with normalized phrasing: 'Most people miss doses — how many did you miss this week?' Train technicians to ask it during workup, every visit, and document the answer.
• Watch refill gaps. A 30-day bottle that lasts 60 days is a data point no interview will surface. Where your EHR or pharmacy integrations expose fill dates, build a monthly refill-gap report; where they don't, ask patients to bring bottles and note the fill date on the label.
• Treat the no-show as a red flag. The patient who misses pressure checks is disproportionately the patient who's off drops. Glaucoma no-shows deserve the same recovery-call discipline as post-op patients.

Remove the real barriers

Most nonadherence has a boring cause: cost, complexity, physical difficulty, or forgetting. Each has a practice-level response. Cost: know your formulary alternatives and generic equivalents before the visit ends, and flag prior-auth-required drugs so the patient never hits a surprise at the counter. Complexity: every regimen simplification — combination drops, once-daily agents, aligning drop times with existing habits — pays adherence dividends larger than most escalations. Physical difficulty: arthritis defeats more regimens than defiance does; drop-aid devices and a two-minute instillation teach-back with a technician fix what lectures can't. Forgetting: anchor drops to brushing teeth, set phone alarms in the exam room, involve a family member with permission.

Run a structured call program

Between visits, a short scripted call — new-start patients at two weeks, escalated regimens at one month, refill-gap flags as they appear — catches problems while they're fixable. The script is simple: confirm the regimen, ask the normalized missed-dose question, screen for side effects and cost trouble, remind about the next visit. Document every answer; escalate anything clinical. None of it requires a license, which is why optometry and ophthalmology practices alike hand the calling, tracking, and reporting to a trained eye care virtual assistant at a flat $10/hour — steady administrative persistence in service of a clinical outcome.

Measure the program, not the sentiment

Three numbers monthly: percentage of glaucoma patients with a documented adherence conversation, refill-gap flags worked to resolution, and no-show recovery rate for pressure checks. Practices that run this machinery see fewer surprise escalations and — the quiet win — fewer patients progressing on paper-perfect regimens they were never actually taking. For the visit-cadence side of chronic disease management, see our AMD monitoring program guide.